Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11458433 | PMC |
| http://dx.doi.org/10.3389/fcell.2024.1496001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Here we report results of a phase 1 multi-institutional, open-label, dose-escalation trial (NCT02744287) of BPX-601, an investigational autologous PSCA-directed GoCAR-T® cell product containing an inducible MyD88/CD40 ON-switch responsive to the activating dimerizer rimiducid, in patients with metastatic pancreatic (mPDAC) or castration-resistant prostate cancer (mCRPC). Primary objectives were to evaluate safety and tolerability and determine the recommended phase 2 dose/schedule (RP2D). Secondary objectives included the assessment of efficacy and characterization of the pharmacokinetics of rimiducid.
View Article and Find Full Text PDFChemistry - A European Journal Turns 30.
Chemistry
December 2024
Wiley-VCH GmbH Chemistry - A European Journal, 69469, Weinheim, Germany.
In this editorial, the Editor-in-Chief reflects on the launch of Chemistry - A European Journal 30 years ago and the development of the journal since then. In the year of its 30 anniversary, the journal will continue its legacy of excellence and innovation in the field of chemistry and remains committed to representing modern chemistry and adapting to emerging trends and topics.
View Article and Find Full Text PDFPhase Ib/II study of imprime PGG and pembrolizumab in patients with previously treated advanced non-small cell lung cancer (NSCLC): BTCRC LUN 15-017.
Transl Lung Cancer Res
November 2024
Division of Hematology-Oncology, Department of Medicine, University of Illinois, Chicago, IL, USA.
Background: Therapeutic strategies to engage anti-tumor innate immunity are still underdeveloped. Imprime PGG (imprime), a pathogen-associated molecular pattern (PAMP), through pattern recognition receptors, successfully illicit a broad-based innate immune response in preclinical models against various cancers. We aimed to study safety and efficacy of imprime in combination with pembrolizumab in advanced stage non-small cell lung cancer (NSCLC).
View Article and Find Full Text PDFFocused review on artificial intelligence for disease detection in infants.
Front Digit Health
November 2024
Division of Phoniatrics, Medical University of Graz, Graz, Austria.
Over the last years, studies using artificial intelligence (AI) for the detection and prediction of diseases have increased and also concentrated more and more on vulnerable groups of individuals, such as infants. The release of ChatGPT demonstrated the potential of large language models (LLMs) and heralded a new era of AI with manifold application possibilities. However, the impact of this new technology on medical research cannot be fully estimated yet.
View Article and Find Full Text PDFTurning the Page at : Charting a Legacy of Excellence in the Digital Era.
AJNR Am J Neuroradiol
December 2024
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!